Genetically engineered Sertoli cells are able to survive allogeneic transplantation (Q44729088)

5 December 2017

title

Genetically engineered Sertoli cells are able to survive allogeneic transplantation (English)

1 reference

5 December 2017

Dufour JM

1

1 reference

5 December 2017

Hemendinger R

2

1 reference

5 December 2017

Halberstadt CR

3

1 reference

5 December 2017

Gores P

4

1 reference

5 December 2017

Emerich DF

5

1 reference

5 December 2017

Korbutt GS

6

1 reference

5 December 2017

Rajotte RV

7

1 reference

5 December 2017

publication date

1 April 2004

1 reference

5 December 2017

1 reference

5 December 2017

volume

11

1 reference

5 December 2017

issue

8

1 reference

5 December 2017

page(s)

694-700

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302218

5 December 2017

exact match

0 references

cites work

Unraveling immune privilege

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

Long-term survival of neonatal porcine Sertoli cells in non-immunosuppressed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

Survival of rat and porcine Sertoli cell transplants in the rat striatum without cyclosporine-A immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

Sertoli cells decrease microglial response and increase engraftment of human hNT neurons in the hemiparkinsonian rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

Progress and problems with the use of viral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

Immune response to green fluorescent protein: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

Size matters: use of YACs, BACs and PACs in transgenic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

Biotechnology in reproductive medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

Transgenic pig expressing the enhanced green fluorescent protein produced by nuclear transfer using colchicine-treated fibroblasts as donor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

Recombinant antithrombin: production and role in cardiovascular disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

Transgenic milk as a method for the production of recombinant antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

Generating green fluorescent mice by germline transmission of green fluorescent ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

A role for CD95 ligand in preventing graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

Long-term survival of intratesticular porcine islets in nonimmunosuppressed beagles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

7 January 2021

Successful islet/abdominal testis transplantation does not require Leydig cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

7 January 2021

Prolonged intratesticular islet allograft survival is not dependent on local steroidogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

7 January 2021

The role of germinal epithelium and spermatogenesis in the privileged survival of intratesticular grafts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

7 January 2021

Sertoli cell-enriched fractions in successful islet cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

7 January 2021

Co-encapsulation of Sertoli enriched testicular cell fractions further prolongs fish-to-mouse islet xenograft survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

7 January 2021

Immunoprotection of rat islet xenografts by cotransplantation with sertoli cells and a single injection of antilymphocyte serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

7 January 2021

Development of an immunoprivileged site to prolong islet allograft survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

7 January 2021

Testicular Sertoli cells exert both protective and destructive effects on syngeneic islet grafts in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

7 January 2021

Testicular sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta1-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302218

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302218

1 reference

5 December 2017

1 reference